Mymetics Corporation (MYMX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Dec 12, 2025
Mymetics Revenue
Mymetics had revenue of 34.00K EUR in the quarter ending September 30, 2023, a decrease of -73.85%. This brings the company's revenue in the last twelve months to 533.00K, down -44.71% year-over-year. In the year 2022, Mymetics had annual revenue of 1.03M with 139.07% growth.
Revenue (ttm)
533.00K EUR
Revenue Growth
-44.71%
P/S Ratio
0.00
Revenue / Employee
266.50K EUR
Employees
2
Market Cap
46.00 USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1.03M | 598.00K | 139.07% |
| Dec 31, 2021 | 430.00K | -238.00K | -35.63% |
| Dec 31, 2020 | 668.00K | 15.00K | 2.30% |
| Dec 31, 2019 | 653.00K | -314.00K | -32.47% |
| Dec 31, 2018 | 967.00K | -548.00K | -36.17% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neurobiological Technologies | 25.32M |
| Genocea Biosciences | 1.91M |
| Baudax Bio | 1.27M |
| Comera Life Sciences Holdings | 1.00M |
| Core One Labs | 338.91K |
| Bioasis Technologies | 199.01K |
| Panacos Pharmaceuticals | 99.00K |
| Athersys | 80.00K |